Lana Gramatyuk
President of the Ukrainian Association of Biobanks, Director of the Institute of Clinical Bio-Rehabilitation, Head of the Working Group on Scientific Research of the European Association biobanks.
A member of the working group from the development and promotion of standards for the nutrition of stem cells in IASC . Scientific degree at the Medical University of Graz, Professor, PhD, Master of Medicine with a specialization in Biobanking. Working experience is more than 28 years.
The main direct results of the study: organization and management of the biobanking and biotechnology system, organization and control of the quality of biological material, organization and audit of biobanks and biotechnological laboratories, scientific research on the cultivation of new forms of cell cultures, development and control of medical protocols, individual selection of biotechnological programs for treatment and rejuvenation.
As Medical Director of Research Biobanking, she is responsible for the strategic and medical oversight of biobank operations that support translational and clinical research. The role focuses on integrating biobanking activities with the scientific priorities of academic institutions, clinical centers, and funding organizations, ensuring that biospecimen resources effectively advance medical research and innovation.
She leads the development and implementation of long-term research strategies for biobanking, aligning sample acquisition, processing, and distribution with ethically approved research objectives. A key aspect of my work is ensuring full compliance with international ethical standards, regulatory frameworks, and best clinical practices governing human biological materials, including informed consent, donor protection, and responsible data use.
Lana oversees the management of biospecimens and associated clinical and molecular data, establishing robust quality assurance (QA) and quality control (QC) systems to ensure the accuracy, traceability, and reproducibility of samples throughout their lifecycle. This includes continuous assessment of the clinical relevance and scientific value of stored materials, as well as optimization of biobank workflows, technologies, and infrastructure.
In addition, she actively promotes collaboration between the biobank and national and international research teams, providing scientific support, methodological guidance, and training for investigators utilizing biobank resources. Also responsible for maintaining strict standards of data confidentiality, biosecurity, and information governance, ensuring the protection of patient privacy and research integrity. Continuous process evaluation and innovation remain central to improving operational efficiency, data quality, and the translational impact of biobanking activities.